Earlier today, the Medicare Access for Patients Rx Coalition (MAPRx) provided the Centers for Medicare & Medicaid Services (CMS) with our official commentary in response to the Advance Notice of Methodological Changes for Calendar Year 2021 for Medicare Advantage Capitation…
Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Senators Bill Cassidy and Bob Menendez in support of their legislation to address out-of-pocket (OOP) costs for Medicare Part D beneficiaries.…
Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Congressional leadership urging them to take action to address the looming increase in out-of-pocket (OOP) costs Medicare Part D beneficiaries will…
Earlier today, the MAPRx Coalition submitted feedback and comments on Title III of H.R. 3, the Lower Drug Costs Now Act of 2019, to the Chairs and Ranking Members of the House of Representatives’ Ways & Means, Energy & Commerce, and…
Today, the MAPRx Coalition and 28 of its members, national organizations representing patients, caregivers, and healthcare professionals, submitted a letter to the Senate Finance Committee on their recently released legislation, The 2019 Prescription Drug Pricing Reduction Act of 2019. The Coalition…
On June 6, MAPRx and 45 national advocacy organizations submitted a letter to leadership in the House of Representatives’ Ways and Means Committee and Energy and Commerce Committee with recommendations for improving Medicare Part D. Among other improvements, the letter…